The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Soft Capsules Drugs CMO Market Research Report 2025
Synopsis
The company supply Softgel Capsule contract pharmaceutical manufacturing services
The global Soft Capsules Drugs CMO market was valued at US$ 7651 million in 2023 and is anticipated to reach US$ 10760 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Soft Capsules Drugs CMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soft Capsules Drugs CMO.
Report Scope
The Soft Capsules Drugs CMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Soft Capsules Drugs CMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Soft Capsules Drugs CMO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Aenova
Nature's Bounty
Procaps
Patheon (Thermo Fisher Scientific)
IVC
EuroCaps
Captek
Strides Pharma Science
Lonza (Capsugel)
Soft Gel Technologies
Sirio Pharma
Segment by Type
Gelatin Type
Non-animal Type
Segment by Application
Health Supplements
Pharmaceutical
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Soft Capsules Drugs CMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The company supply Softgel Capsule contract pharmaceutical manufacturing services
The global Soft Capsules Drugs CMO market was valued at US$ 7651 million in 2023 and is anticipated to reach US$ 10760 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Soft Capsules Drugs CMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soft Capsules Drugs CMO.
Report Scope
The Soft Capsules Drugs CMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Soft Capsules Drugs CMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Soft Capsules Drugs CMO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Aenova
Nature's Bounty
Procaps
Patheon (Thermo Fisher Scientific)
IVC
EuroCaps
Captek
Strides Pharma Science
Lonza (Capsugel)
Soft Gel Technologies
Sirio Pharma
Segment by Type
Gelatin Type
Non-animal Type
Segment by Application
Health Supplements
Pharmaceutical
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Soft Capsules Drugs CMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Soft Capsules Drugs CMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Gelatin Type
1.2.3 Non-animal Type
1.3 Market by Application
1.3.1 Global Soft Capsules Drugs CMO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Health Supplements
1.3.3 Pharmaceutical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Soft Capsules Drugs CMO Market Perspective (2019-2030)
2.2 Soft Capsules Drugs CMO Growth Trends by Region
2.2.1 Global Soft Capsules Drugs CMO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Soft Capsules Drugs CMO Historic Market Size by Region (2019-2024)
2.2.3 Soft Capsules Drugs CMO Forecasted Market Size by Region (2025-2030)
2.3 Soft Capsules Drugs CMO Market Dynamics
2.3.1 Soft Capsules Drugs CMO Industry Trends
2.3.2 Soft Capsules Drugs CMO Market Drivers
2.3.3 Soft Capsules Drugs CMO Market Challenges
2.3.4 Soft Capsules Drugs CMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Soft Capsules Drugs CMO Players by Revenue
3.1.1 Global Top Soft Capsules Drugs CMO Players by Revenue (2019-2024)
3.1.2 Global Soft Capsules Drugs CMO Revenue Market Share by Players (2019-2024)
3.2 Global Soft Capsules Drugs CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Soft Capsules Drugs CMO Revenue
3.4 Global Soft Capsules Drugs CMO Market Concentration Ratio
3.4.1 Global Soft Capsules Drugs CMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Soft Capsules Drugs CMO Revenue in 2023
3.5 Soft Capsules Drugs CMO Key Players Head office and Area Served
3.6 Key Players Soft Capsules Drugs CMO Product Solution and Service
3.7 Date of Enter into Soft Capsules Drugs CMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Soft Capsules Drugs CMO Breakdown Data by Type
4.1 Global Soft Capsules Drugs CMO Historic Market Size by Type (2019-2024)
4.2 Global Soft Capsules Drugs CMO Forecasted Market Size by Type (2025-2030)
5 Soft Capsules Drugs CMO Breakdown Data by Application
5.1 Global Soft Capsules Drugs CMO Historic Market Size by Application (2019-2024)
5.2 Global Soft Capsules Drugs CMO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Soft Capsules Drugs CMO Market Size (2019-2030)
6.2 North America Soft Capsules Drugs CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Soft Capsules Drugs CMO Market Size by Country (2019-2024)
6.4 North America Soft Capsules Drugs CMO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Soft Capsules Drugs CMO Market Size (2019-2030)
7.2 Europe Soft Capsules Drugs CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Soft Capsules Drugs CMO Market Size by Country (2019-2024)
7.4 Europe Soft Capsules Drugs CMO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Soft Capsules Drugs CMO Market Size (2019-2030)
8.2 Asia-Pacific Soft Capsules Drugs CMO Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Soft Capsules Drugs CMO Market Size by Region (2019-2024)
8.4 Asia-Pacific Soft Capsules Drugs CMO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Soft Capsules Drugs CMO Market Size (2019-2030)
9.2 Latin America Soft Capsules Drugs CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Soft Capsules Drugs CMO Market Size by Country (2019-2024)
9.4 Latin America Soft Capsules Drugs CMO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Soft Capsules Drugs CMO Market Size (2019-2030)
10.2 Middle East & Africa Soft Capsules Drugs CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Soft Capsules Drugs CMO Market Size by Country (2019-2024)
10.4 Middle East & Africa Soft Capsules Drugs CMO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Detail
11.1.2 Catalent Business Overview
11.1.3 Catalent Soft Capsules Drugs CMO Introduction
11.1.4 Catalent Revenue in Soft Capsules Drugs CMO Business (2019-2024)
11.1.5 Catalent Recent Development
11.2 Aenova
11.2.1 Aenova Company Detail
11.2.2 Aenova Business Overview
11.2.3 Aenova Soft Capsules Drugs CMO Introduction
11.2.4 Aenova Revenue in Soft Capsules Drugs CMO Business (2019-2024)
11.2.5 Aenova Recent Development
11.3 Nature's Bounty
11.3.1 Nature's Bounty Company Detail
11.3.2 Nature's Bounty Business Overview
11.3.3 Nature's Bounty Soft Capsules Drugs CMO Introduction
11.3.4 Nature's Bounty Revenue in Soft Capsules Drugs CMO Business (2019-2024)
11.3.5 Nature's Bounty Recent Development
11.4 Procaps
11.4.1 Procaps Company Detail
11.4.2 Procaps Business Overview
11.4.3 Procaps Soft Capsules Drugs CMO Introduction
11.4.4 Procaps Revenue in Soft Capsules Drugs CMO Business (2019-2024)
11.4.5 Procaps Recent Development
11.5 Patheon (Thermo Fisher Scientific)
11.5.1 Patheon (Thermo Fisher Scientific) Company Detail
11.5.2 Patheon (Thermo Fisher Scientific) Business Overview
11.5.3 Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Introduction
11.5.4 Patheon (Thermo Fisher Scientific) Revenue in Soft Capsules Drugs CMO Business (2019-2024)
11.5.5 Patheon (Thermo Fisher Scientific) Recent Development
11.6 IVC
11.6.1 IVC Company Detail
11.6.2 IVC Business Overview
11.6.3 IVC Soft Capsules Drugs CMO Introduction
11.6.4 IVC Revenue in Soft Capsules Drugs CMO Business (2019-2024)
11.6.5 IVC Recent Development
11.7 EuroCaps
11.7.1 EuroCaps Company Detail
11.7.2 EuroCaps Business Overview
11.7.3 EuroCaps Soft Capsules Drugs CMO Introduction
11.7.4 EuroCaps Revenue in Soft Capsules Drugs CMO Business (2019-2024)
11.7.5 EuroCaps Recent Development
11.8 Captek
11.8.1 Captek Company Detail
11.8.2 Captek Business Overview
11.8.3 Captek Soft Capsules Drugs CMO Introduction
11.8.4 Captek Revenue in Soft Capsules Drugs CMO Business (2019-2024)
11.8.5 Captek Recent Development
11.9 Strides Pharma Science
11.9.1 Strides Pharma Science Company Detail
11.9.2 Strides Pharma Science Business Overview
11.9.3 Strides Pharma Science Soft Capsules Drugs CMO Introduction
11.9.4 Strides Pharma Science Revenue in Soft Capsules Drugs CMO Business (2019-2024)
11.9.5 Strides Pharma Science Recent Development
11.10 Lonza (Capsugel)
11.10.1 Lonza (Capsugel) Company Detail
11.10.2 Lonza (Capsugel) Business Overview
11.10.3 Lonza (Capsugel) Soft Capsules Drugs CMO Introduction
11.10.4 Lonza (Capsugel) Revenue in Soft Capsules Drugs CMO Business (2019-2024)
11.10.5 Lonza (Capsugel) Recent Development
11.11 Soft Gel Technologies
11.11.1 Soft Gel Technologies Company Detail
11.11.2 Soft Gel Technologies Business Overview
11.11.3 Soft Gel Technologies Soft Capsules Drugs CMO Introduction
11.11.4 Soft Gel Technologies Revenue in Soft Capsules Drugs CMO Business (2019-2024)
11.11.5 Soft Gel Technologies Recent Development
11.12 Sirio Pharma
11.12.1 Sirio Pharma Company Detail
11.12.2 Sirio Pharma Business Overview
11.12.3 Sirio Pharma Soft Capsules Drugs CMO Introduction
11.12.4 Sirio Pharma Revenue in Soft Capsules Drugs CMO Business (2019-2024)
11.12.5 Sirio Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Soft Capsules Drugs CMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Gelatin Type
Table 3. Key Players of Non-animal Type
Table 4. Global Soft Capsules Drugs CMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Soft Capsules Drugs CMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Soft Capsules Drugs CMO Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Soft Capsules Drugs CMO Market Share by Region (2019-2024)
Table 8. Global Soft Capsules Drugs CMO Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Soft Capsules Drugs CMO Market Share by Region (2025-2030)
Table 10. Soft Capsules Drugs CMO Market Trends
Table 11. Soft Capsules Drugs CMO Market Drivers
Table 12. Soft Capsules Drugs CMO Market Challenges
Table 13. Soft Capsules Drugs CMO Market Restraints
Table 14. Global Soft Capsules Drugs CMO Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Soft Capsules Drugs CMO Market Share by Players (2019-2024)
Table 16. Global Top Soft Capsules Drugs CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs CMO as of 2023)
Table 17. Ranking of Global Top Soft Capsules Drugs CMO Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Soft Capsules Drugs CMO Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Soft Capsules Drugs CMO Product Solution and Service
Table 21. Date of Enter into Soft Capsules Drugs CMO Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Soft Capsules Drugs CMO Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Soft Capsules Drugs CMO Revenue Market Share by Type (2019-2024)
Table 25. Global Soft Capsules Drugs CMO Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Soft Capsules Drugs CMO Revenue Market Share by Type (2025-2030)
Table 27. Global Soft Capsules Drugs CMO Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Soft Capsules Drugs CMO Revenue Market Share by Application (2019-2024)
Table 29. Global Soft Capsules Drugs CMO Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Soft Capsules Drugs CMO Revenue Market Share by Application (2025-2030)
Table 31. North America Soft Capsules Drugs CMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Soft Capsules Drugs CMO Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Soft Capsules Drugs CMO Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Soft Capsules Drugs CMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Soft Capsules Drugs CMO Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Soft Capsules Drugs CMO Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Soft Capsules Drugs CMO Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Soft Capsules Drugs CMO Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Soft Capsules Drugs CMO Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Soft Capsules Drugs CMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Soft Capsules Drugs CMO Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Soft Capsules Drugs CMO Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Soft Capsules Drugs CMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Soft Capsules Drugs CMO Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Soft Capsules Drugs CMO Market Size by Country (2025-2030) & (US$ Million)
Table 46. Catalent Company Detail
Table 47. Catalent Business Overview
Table 48. Catalent Soft Capsules Drugs CMO Product
Table 49. Catalent Revenue in Soft Capsules Drugs CMO Business (2019-2024) & (US$ Million)
Table 50. Catalent Recent Development
Table 51. Aenova Company Detail
Table 52. Aenova Business Overview
Table 53. Aenova Soft Capsules Drugs CMO Product
Table 54. Aenova Revenue in Soft Capsules Drugs CMO Business (2019-2024) & (US$ Million)
Table 55. Aenova Recent Development
Table 56. Nature's Bounty Company Detail
Table 57. Nature's Bounty Business Overview
Table 58. Nature's Bounty Soft Capsules Drugs CMO Product
Table 59. Nature's Bounty Revenue in Soft Capsules Drugs CMO Business (2019-2024) & (US$ Million)
Table 60. Nature's Bounty Recent Development
Table 61. Procaps Company Detail
Table 62. Procaps Business Overview
Table 63. Procaps Soft Capsules Drugs CMO Product
Table 64. Procaps Revenue in Soft Capsules Drugs CMO Business (2019-2024) & (US$ Million)
Table 65. Procaps Recent Development
Table 66. Patheon (Thermo Fisher Scientific) Company Detail
Table 67. Patheon (Thermo Fisher Scientific) Business Overview
Table 68. Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Product
Table 69. Patheon (Thermo Fisher Scientific) Revenue in Soft Capsules Drugs CMO Business (2019-2024) & (US$ Million)
Table 70. Patheon (Thermo Fisher Scientific) Recent Development
Table 71. IVC Company Detail
Table 72. IVC Business Overview
Table 73. IVC Soft Capsules Drugs CMO Product
Table 74. IVC Revenue in Soft Capsules Drugs CMO Business (2019-2024) & (US$ Million)
Table 75. IVC Recent Development
Table 76. EuroCaps Company Detail
Table 77. EuroCaps Business Overview
Table 78. EuroCaps Soft Capsules Drugs CMO Product
Table 79. EuroCaps Revenue in Soft Capsules Drugs CMO Business (2019-2024) & (US$ Million)
Table 80. EuroCaps Recent Development
Table 81. Captek Company Detail
Table 82. Captek Business Overview
Table 83. Captek Soft Capsules Drugs CMO Product
Table 84. Captek Revenue in Soft Capsules Drugs CMO Business (2019-2024) & (US$ Million)
Table 85. Captek Recent Development
Table 86. Strides Pharma Science Company Detail
Table 87. Strides Pharma Science Business Overview
Table 88. Strides Pharma Science Soft Capsules Drugs CMO Product
Table 89. Strides Pharma Science Revenue in Soft Capsules Drugs CMO Business (2019-2024) & (US$ Million)
Table 90. Strides Pharma Science Recent Development
Table 91. Lonza (Capsugel) Company Detail
Table 92. Lonza (Capsugel) Business Overview
Table 93. Lonza (Capsugel) Soft Capsules Drugs CMO Product
Table 94. Lonza (Capsugel) Revenue in Soft Capsules Drugs CMO Business (2019-2024) & (US$ Million)
Table 95. Lonza (Capsugel) Recent Development
Table 96. Soft Gel Technologies Company Detail
Table 97. Soft Gel Technologies Business Overview
Table 98. Soft Gel Technologies Soft Capsules Drugs CMO Product
Table 99. Soft Gel Technologies Revenue in Soft Capsules Drugs CMO Business (2019-2024) & (US$ Million)
Table 100. Soft Gel Technologies Recent Development
Table 101. Sirio Pharma Company Detail
Table 102. Sirio Pharma Business Overview
Table 103. Sirio Pharma Soft Capsules Drugs CMO Product
Table 104. Sirio Pharma Revenue in Soft Capsules Drugs CMO Business (2019-2024) & (US$ Million)
Table 105. Sirio Pharma Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Soft Capsules Drugs CMO Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Soft Capsules Drugs CMO Market Share by Type: 2023 VS 2030
Figure 3. Gelatin Type Features
Figure 4. Non-animal Type Features
Figure 5. Global Soft Capsules Drugs CMO Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Soft Capsules Drugs CMO Market Share by Application: 2023 VS 2030
Figure 7. Health Supplements Case Studies
Figure 8. Pharmaceutical Case Studies
Figure 9. Others Case Studies
Figure 10. Soft Capsules Drugs CMO Report Years Considered
Figure 11. Global Soft Capsules Drugs CMO Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Soft Capsules Drugs CMO Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Soft Capsules Drugs CMO Market Share by Region: 2023 VS 2030
Figure 14. Global Soft Capsules Drugs CMO Market Share by Players in 2023
Figure 15. Global Top Soft Capsules Drugs CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs CMO as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Soft Capsules Drugs CMO Revenue in 2023
Figure 17. North America Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Soft Capsules Drugs CMO Market Share by Country (2019-2030)
Figure 19. United States Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Soft Capsules Drugs CMO Market Share by Country (2019-2030)
Figure 23. Germany Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Soft Capsules Drugs CMO Market Share by Region (2019-2030)
Figure 31. China Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Soft Capsules Drugs CMO Market Share by Country (2019-2030)
Figure 39. Mexico Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Soft Capsules Drugs CMO Market Share by Country (2019-2030)
Figure 43. Turkey Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Soft Capsules Drugs CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Catalent Revenue Growth Rate in Soft Capsules Drugs CMO Business (2019-2024)
Figure 46. Aenova Revenue Growth Rate in Soft Capsules Drugs CMO Business (2019-2024)
Figure 47. Nature's Bounty Revenue Growth Rate in Soft Capsules Drugs CMO Business (2019-2024)
Figure 48. Procaps Revenue Growth Rate in Soft Capsules Drugs CMO Business (2019-2024)
Figure 49. Patheon (Thermo Fisher Scientific) Revenue Growth Rate in Soft Capsules Drugs CMO Business (2019-2024)
Figure 50. IVC Revenue Growth Rate in Soft Capsules Drugs CMO Business (2019-2024)
Figure 51. EuroCaps Revenue Growth Rate in Soft Capsules Drugs CMO Business (2019-2024)
Figure 52. Captek Revenue Growth Rate in Soft Capsules Drugs CMO Business (2019-2024)
Figure 53. Strides Pharma Science Revenue Growth Rate in Soft Capsules Drugs CMO Business (2019-2024)
Figure 54. Lonza (Capsugel) Revenue Growth Rate in Soft Capsules Drugs CMO Business (2019-2024)
Figure 55. Soft Gel Technologies Revenue Growth Rate in Soft Capsules Drugs CMO Business (2019-2024)
Figure 56. Sirio Pharma Revenue Growth Rate in Soft Capsules Drugs CMO Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
